Kekule Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 6.90 Cr
as on 23-10-2024
- Company Age 11 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 16.34 Cr
as on 23-10-2024
- Satisfied Charges ₹ 5.01 Cr
as on 23-10-2024
- Revenue -36.64%
(FY 2023)
- Profit -28.93%
(FY 2023)
- Ebitda 34.70%
(FY 2023)
- Net Worth -13.82%
(FY 2023)
- Total Assets -12.95%
(FY 2023)
About Kekule Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 6.90 Cr.
The company currently has active open charges totaling ₹16.34 Cr. The company has closed loans amounting to ₹5.01 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kudaravalli Rao, Kudaravalli Sridhar, Srilakshmi Kudaravalli, and Three other members serve as directors at the Company.
- CIN/LLPIN
U74900TG2013PLC089588
- Company No.
089588
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
20 Aug 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Kekule Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sridhar Vootla  | Managing Director | 20-Aug-2013 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kudaravalli Rao | Director | 20-Aug-2013 | Current |
| Kudaravalli Sridhar | Director | 20-Aug-2013 | Current |
| Srilakshmi Kudaravalli | Director | 11-Oct-2019 | Current |
| Adarsh Kacham | Director | 20-Aug-2013 | Current |
| Apparao Vootla | Director | 20-Aug-2013 | Current |
Financial Performance and Corporate Structure Insights of Kekule Life Sciences.
Kekule Life Sciences Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 36.64% decrease. The company also saw a substantial fall in profitability, with a 28.93% decrease in profit. The company's net worth observed a substantial decline by a decrease of 13.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kekule Life Sciences?
In 2023, Kekule Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kekule Pharma LimitedActive 40 years 20 daysKudaravalli Rao, Kudaravalli Sridhar and 1 more are mutual person
- Kekule Pharmaceuticals (A.P) LimitedActive 9 years 8 months
Kudaravalli Rao and Srilakshmi Kudaravalli are mutual person
- Dura Lifesciences LimitedActive 16 years 10 months
Kudaravalli Rao and Srilakshmi Kudaravalli are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Mar 2023 | ₹5.70 M | Open |
Others Creation Date: 10 Jul 2020 | ₹1.27 Cr | Open |
Bank Of Baroda Creation Date: 17 Sep 2014 | ₹14.50 Cr | Open |
How Many Employees Work at Kekule Life Sciences?
Kekule Life Sciences has a workforce of 40 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kekule Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kekule Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
